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Since Fontan and Baudet’s report1 of the first successfulright heart bypass directing the entire systemic venous
blood flow to the pulmonary arteries in a patient with tri-
cuspid atresia, a large amount of experimental and surgi-
cal work has been done to improve the prognosis of
patients in whom a biventricular repair cannot be
achieved. Once the feasibility of pulmonary arterial per-
fusion without a pumping chamber was demonstrated
clinically, several techniques to connect the systemic
venous atrium with the central pulmonary arteries were
developed.2 However, intermediate and long-term results
soon showed that incorporation of the entire systemic
venous atrium in the Fontan circulation was associated
with a high incidence of supraventricular tachyarrhyth-
mias (SVTs) and thromboembolic complications.3-7
Objectives: Completion of a total cavopulmonary anastomosis with an intra-
atrial lateral tunnel is known to yield good early and midterm results. In this
study, we sought to determine the long-term outcome (10 years) after a lat-
eral tunnel Fontan procedure. 
Methods: Between October 1987 and December 1991, 220 patients (aged 11
months to 32 years) with a wide range of underlying diagnoses underwent a
fenestrated or nonfenestrated lateral tunnel Fontan procedure at our institu-
tion. Current follow-up information was available for 196 patients (94%,
mean follow-up = 10.2 ± 0.6 years). Risk factor analysis included patient-
related and procedure-related variables, with death, failure, and brady-
arrhythmia or tachyarrhythmia as outcome parameters.
Results: There were 12 early deaths (<30 days or hospital death), 7 late
deaths, 4 successful takedown operations, and 4 heart transplantations.
Kaplan-Meier estimated survival was 93% at 5 years and 91% at 10 years,
and freedom from failure was 90% at 5 years and 87% at 10 years. Freedom
from new supraventricular tachyarrhythmia was 96% at 5 years and 91% at
10 years; freedom from new bradyarrhythmia was 88% at 5 years and 79%
at 10 years. Three patients had evidence of protein-losing enteropathy.
Multivariable risk factors for development of supraventricular tachyarrhyth-
mia included heterotaxy syndrome, atrioventricular valve abnormalities, and
preoperative bradyarrhythmia. Risk factors for bradyarrhythmia included
systemic venous anomalies. The sole risk factor for late failure was a previ-
ous coarctation repair.
Conclusion: The lateral tunnel Fontan procedure results in excellent long-
term outcome even when used in patients with diverse anatomic diagnoses.
The incidence of atrial tachyarrhythmia is low and mainly depends on the
underlying cardiac morphology and preoperative arrhythmia. The good long-
term outcome after an intracardiac lateral tunnel Fontan procedure should
serve as a basis for comparison with other surgical alternatives. (J Thorac
Cardiovasc Surg 2001;121:28-41)
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Turbulent blood flow in the systemic venous atrium with
parietal stasis increases the risk of thrombus formation,
and elevated atrial pressure facilitates distention of the
atrial wall, progressive right atrial enlargement, and con-
duction abnormalities. Hence, de Leval and associates8
and Jonas and Castaneda9 developed a technique to guide
the systemic venous return from the inferior vena cava
(IVC) to the orifice of the superior vena cava (SVC)
through an intra-atrial tunnel that consists of a prosthetic
baffle and incorporates a portion of the lateral atrial wall.
The concept was to achieve laminar blood flow in a tubu-
lar construct and to provide growth potential, as well as a
source for endothelialization of the synthetic surface. The
lateral tunnel Fontan operation has since been performed
in large series with low operative and intermediate mor-
tality, but little information is available regarding the
long-term outcome. To date, studies of long-term results
after Fontan operations are mainly based on patients with
direct atriopulmonary anastomoses and rarely allow a
valid assessment of the long-term outcome after a lateral
tunnel Fontan procedure.4,6,10 A study covering the first
500 patients undergoing any modification of the Fontan
operation at our institution included our initial experience
with a lateral tunnel Fontan operation, but only short-term
follow-up was available for this subgroup of patients.11,12
In view of the current controversy regarding the indica-
tions for a total extracardiac Fontan procedure, we now
sought to determine the long-term outcome of the first
220 patients who underwent a lateral tunnel Fontan pro-
cedure at Children’s Hospital Boston.
Methods
Patients undergoing a total cavopulmonary anastomosis
with an intra-atrial lateral tunnel at Children’s Hospital
Boston between October 1987 and December 1991 were
identified from the databases of the Departments of Cardiac
Surgery and Cardiology. This cohort includes patients with an
interrupted IVC and azygos continuation in whom the hepat-
ic venous blood flow was directed to the orifice of the SVC
by means of a typical lateral intra-atrial tunnel. Four patients
who underwent a lateral tunnel Fontan operation as a conver-
sion from a previous atriopulmonary anastomosis were
excluded.13 Also excluded were 3 patients in whom an intra-
atrial lateral tunnel guides blood flow from the IVC to the
entrance of a right-sided atrial appendage, which was con-
nected with the pulmonary arteries distally.
Medical records, operative notes, all available electrocar-
diograms (ECGs), echocardiography reports, and cardiac
catheterization reports were reviewed. In cases in which no
current follow-up information was available, primary physi-
cians and cardiologists monitoring the patient were contact-
ed. Preoperative data were partly incorporated in previous
studies from our institution, but all data were re-evaluated
because the group termed total cavopulmonary anastomosis
in the studies by Gentles,10 Fishberger,12 and their associates
also included a number of patients in whom no lateral tunnel
was inserted but instead the atrial septal defect was closed or
the pulmonary venous return routed to the atrioventricular
valve(s) by means of a complex intra-atrial patch.
Surgical technique. After median sternotomy, bicaval can-
nulation, and aortic cannulation, all patients were placed on
hypothermic cardiopulmonary bypass. Aortic crossclamping
and cardioplegic arrest were performed in all but 5 patients. The
pulmonary artery was divided, the proximal end closed, any
systemic–pulmonary arterial shunts taken down, and a pul-
monary arterioplasty was performed when indicated. The right-
sided atrium was then opened parallel to the sulcus terminalis
but more anterior than for other intra-atrial procedures, and the
atrial septum was excised within the confines of the limbus of
the fossa ovalis to ensure unobstructed communication between
the atria. A polytetrafluoroethylene (PTFE)* cardiovascular
patch or a PTFE tube graft (10-18 mm diameter) that had been
opened longitudinally was inserted so as to direct blood flow
from the IVC to the orifice of the SVC or superior end of the
right atrium, incorporating a portion of the lateral atrial wall in
the newly constructed tunnel. The exact position of the suture
line was not always clear from the operative report, and some
variations may have occurred as a result of anatomic features
and the surgeon’s preference. In general, the suture starts
between the orifices of the IVC and coronary sinus and is car-
ried toward the SVC orifice, staying anterior to the posterior rim
of the atrial septum to avoid pulmonary venous obstruction.
Around the SVC orifice, sutures are placed into the nontrabec-
ulated tissue at the SVC entrance site, posterior to the crista ter-
minalis. In cases in which the crista terminalis has to be used for
secure anchorage of the patch, stitches are placed superficially
to prevent damage to conduction pathways following the crista
terminalis muscle bundles. The suture is then carried along the
lateral atrial wall toward the IVC orifice, then around the IVC
orifice, leaving the coronary sinus on the pulmonary venous
atrial side of the baffle. In a subgroup of patients a small (3-4
mm) fenestration was created in the PTFE baffle with a coro-
nary punch. Finally, the cavopulmonary anastomosis was con-
structed, the technique depending on the anatomy of the SVC
and the presence of a prior bidirectional Glenn shunt.
Definitions. Supraventricular tachyarrhythmia (SVT) was
defined as the presence of documented atrial fibrillation, atri-
al flutter, or atrioventricular reciprocating tachycardia, but
not sinus tachycardia. The definition of bradyarrhythmia
included sinus bradycardia, abrupt and pronounced sinus
pause or arrest, sick sinus syndrome,14 slow junctional escape
rhythm, junctional rhythm at physiologic rates without evi-
dence of sinus node activity, and second- or third-degree atri-
oventricular block. Sinus bradycardia was defined as a rest-
ing heart rate of more than 2 standard deviations less than the
age-adjusted mean. For patients followed up at our institu-
tion, the presence of arrhythmia was confirmed by reviewing
the ECG recording. For patients who underwent follow-up
examinations elsewhere, all arrhythmias that were reported in
the correspondence were noted, without an attempt to deter-
*Gore-Tex patch or graft; registered trade mark of W. L Gore &
Associates, Inc, Flagstaff, Ariz.
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mine significance. New postoperative arrhythmia was
defined as the occurrence of arrhythmia after the Fontan
operation, including the early postoperative period, in
patients without evidence of preoperative arrhythmia. Late-
onset arrhythmia was defined as the occurrence of arrhyth-
mia during the follow-up period in patients without evidence
of preoperative or early postoperative arrhythmia. The early
postoperative period was defined as the time before dis-
charge from the hospital or the first 30 postoperative days for
patients who were hospitalized for more than 30 postopera-
tive days.
Statistical analysis. Variables tested for influence on the
outcome parameters are listed in the appendix. Outcome
parameters were overall death, early death, late death, overall
Fontan failure (defined as death, takedown, or transplanta-
tion), early failure, late failure, presence of early and late
SVT, and presence of early and late bradyarrhythmia. The
incidences of new postoperative bradyarrhythmia or SVT
were analyzed as separate outcomes. Estimated actuarial sur-
vival and freedom from failure, SVT, and bradyarrhythmia
were determined by the Kaplan-Meier product-limit method
with 95% confidence intervals (CIs) calculated by means of
the Greenwood formula.15 Significance was assessed in the
univariable analysis by the log-rank test for late and total out-
comes and by the likelihood ratio χ2 test for early outcomes.
For multivariable analysis, the Cox proportional-hazards
regression model was used to establish the variables indepen-
dently predictive of late and total survival, Fontan failure, and
arrhythmias. For outcomes occurring during the early post-
operative period, stepwise logistic regression analysis was
performed. Hazard ratios and odds ratios with 95% confi-
dence intervals were constructed for the significant multivari-
able predictors. Final models were derived by the forward
stepwise selection procedure with variables having P < .1 in
the univariable analyses entered as candidates into the Cox
and multiple logistic regression models; a P value < .05 was
required for a variable to be retained in the equation. To
account for the often transient nature of SVT, we compared
the proportion of patients having SVT at most recent follow-
up with those having preoperative SVT by the Fisher exact
test. All reported P values are 2-tailed. Statistical analysis
was performed by means of the SPSS software package (ver-
sion 9.0, SPSS, Inc, Chicago, Ill).
Results
Patient characteristics. A total of 220 consecutive
patients were included in the study. The median age at
the time of the operation was 3.9 years (range 11
months to 27 years). A total of 128 patients were male
and 92 were female. The major anatomic diagnoses
included tricuspid atresia in 32 patients and double-
inlet left ventricle in 52 patients. To facilitate data
analysis based on the morphology of the predominant
ventricle and its relation to the great arteries, we
assigned the diagnoses to one of the following groups:
single left ventricle with normally related great arteries
(n = 63), single left ventricle with transposed great
arteries (n = 81), single right ventricle excluding
hypoplastic left heart syndrome (n = 26), hypoplastic
left heart syndrome (n = 15), heterotaxy syndrome 
(n = 22), and others (n = 13). Mild or moderate atri-
oventricular valve regurgitation was present in 38
(14%) patients. A total of 47 patients had anomalies of
systemic (n = 40) or pulmonary (n = 12) venous return.
One hundred eighty-seven patients had previously
undergone a total of 348 palliative procedures: 130
patients had a previous systemic–pulmonary artery
shunt, 38 patients had a bidirectional and 13 a classic
Glenn shunt, and 37 of those had a systemic–pul-
monary artery shunt followed by a bidirectional Glenn
shunt. Thirty-two patients had a pulmonary artery–aor-
tic anastomosis in the form of a Damus-Kaye-Stansel
anastomosis (n = 17) or Norwood stage I operation 
(n = 15). Other previous procedures included atrial sep-
tectomy (n = 41), pulmonary artery banding (n = 51),
pulmonary arterioplasty (n = 24), coarctation repair 
(n = 12), and enlargement of a restrictive ventricular
septal defect or bulboventricular foramen (n = 7).
Preoperative cardiac catheterization data were avail-
able in 198 patients and, in conjunction with echocar-
diographic data, served as the basis for assessment of
atrial and ventricular morphology and hemodynamic
data. Mean pulmonary artery pressure was 13.1 ± 4.6
mm Hg (range 5-38 mm Hg), and mean indexed pul-
monary arterial resistance was 1.7 ± 0.9 Wood units
(range 0.4-6.8 Wood units). Four patients had an
indexed pulmonary arterial resistance of more than 4
Wood units, and 9 patients had a pulmonary artery
pressure of more than 20 mm Hg, but a significant
response to high inspired oxygen was noted in most.
Mean right atrial pressure was 6.5 ± 3.2 mm Hg (range
0-21 mm Hg), and mean ventricular end-diastolic pres-
sure was 8.6 ± 3.4 mm Hg (range 0-26 mm Hg).
Patients with elevated ventricular end-diastolic pres-
sure commonly had increased ventricular volume load
with preserved ventricular function. Mean arterial oxy-
gen saturation was 81.5% ± 6.6% (range 57%-94%),
mean hematocrit value was 53.1% ± 4.7% (range 41%-
72%), with a mean hemoglobin value of 16.7 ± 2.1
mg/dL (range 11.8-26.3 mg/dL).
A total of 218 patients had preoperative ECGs, and
47 had undergone prior Holter recordings. In 2 patients
the preoperative rhythm could not be determined on the
basis of the available data. Preoperatively, 182 (83%)
patients were in normal sinus rhythm, and 27 patients
were in bradyarrhythmia. Eleven patients had junction-
al rhythm at a physiologic heart rate, 8 of whom had
undergone construction of a bidirectional Glenn shunt.
Seven (3%) patients had documented preoperative
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SVT, and 11 (5%) patients had had a pacemaker
implanted.
Surgical procedures. Three technical modifications
of the lateral tunnel cavopulmonary anastomosis were
used in this series. The SVC was divided and anasto-
mosed with corresponding incisions in the right pul-
monary artery in 116 patients. The right pulmonary
artery was transected and anastomosed with longitudi-
nal incisions in the SVC in 43 patients. In 62 patients
the superior cavoatrial junction was incised after tran-
section of the SVC. The roof of the right-sided atrium
was then opened and the undersurface of the right pul-
monary artery anastomosed to the orifice composed of
the proximal SVC stump and the right atrial roof. This
modification was developed to minimize the risk of
development of a stenosis at the proximal SVC–pul-
monary artery anastomosis in patients with an SVC ori-
fice that was markedly smaller in diameter than the
IVC. Fenestration of the intra-atrial baffle was per-
formed in 140 (63%) patients. Fenestration of the later-
al tunnel graft was first performed in our institution in
May 1989, so that all patients operated on before that
date had a nonfenestrated intra-atrial baffle. In patients
operated on after May 1989, the indication for baffle
fenestration was mainly based on the presence of pre-
operative elevated pulmonary artery pressure and/or a
pulmonary vascular resistance of more than 2 Wood
units. Concomitant surgical procedures included pul-
monary arterioplasty in 51 patients, atrial septectomy
(n = 144), and takedown of any systemic–pulmonary
artery shunt. Additional intracardiac procedures includ-
ed enlargement of a restrictive bulboventricular fora-
men in 7 patients and atrioventricular valve reconstruc-
tion in 2. Ablation of ectopic atrial foci was performed
in 3 patients. The mean duration of cardiopulmonary
bypass was 120 ± 27 minutes (range 70-273 minutes),
and mean aortic crossclamping time was 59 ± 20 min-
utes (0-111 minutes). Cardiac arrest and myocardial
protection were achieved with oxygenated glucose plus
potassium cardioplegic solution (n = 62), St Thomas’
Table I. Early and late failures after the lateral tunnel Fontan operation
Age at 
Diagnosis operation (y) Cause of failure Interval (mo) Outcome
Early failure
DILV 2.5 Progressive pulmonary hypertension 0.01 Takedown
HLHS 2.8 Low cardiac output 0.01 Death
Single LV 4.0 Low cardiac output 0.01 Death
TA, LPA occlusion 1.7 Cardiac arrest 0.01 Takedown
DORV, hypoplastic LV 3.4 Ventricular dysfunction 0.1 Death
HLHS 2.1 Cardiac arrest 0.2 Death
HLHS 0.9 Low cardiac output/multiorgan failure 0.2 Takedown/death
Single LV, TGA 1.9 Low cardiac output 0.3 Takedown/death
DORV, hypoplastic LV 2.6 Low cardiac output/brain death 0.5 Takedown/death
Single ventricle, D-TGA 1.1 Cerebral bleeding 0.6 Death
Heterotaxy, single LV 2.1 SVC thrombosis, sepsis 1.1 Death
Single RV 6.9 Ventricular dysfunction 1.1 Death
Single LV, L-TGA 4.1 AVVR, sepsis 1.2 Death
TA 2.3 Ventricular dysfunction 2.7 Death
Late failure
TA, TGA 2.5 Persisting effusions 3.0 Takedown
HLHS 2.5 SVC, PA thrombus 6.3 Death
Single LV 11.6 Unknown 8.2 Death
Heterotaxy, single LV 7.4 Baffle thrombosis 8.9 HTX
TA, TGA 2.8 Cerebral thromboembolism 21.4 Death
DORV, hypoplastic LV 2.6 Persisting effusions 31.2 Takedown
DORV, hypoplastic LV 3.9 Ventricular arrhythmia 32.3 Death
TGA, Ebstein’s anomaly 12.3 Ventricular dysfunction, AVVR 44.7 HTX
DORV, ccTGA 21.3 Ventricular dysfunction 57.9 HTX
DORV, mitral atresia 12.4 Ventricular dysfunction, PLE 63.8 Death
CAVC, hypoplastic LV 9.2 Ventricular dysfunction, AVVR 89.4 HTX
Taussig-Bing complex 3.1 Ventricular dysfunction 98.1 Death
DILV 10.7 Aortic regurgitation, ventricular dysfunction 101.9 Death
DILV, Double-inlet left ventricle; HLHS, hypoplastic left heart syndrome; LV, left ventricle; TA, tricuspid atresia; LPA, left pulmonary artery; DORV, double-outlet
right ventricle; TGA, transposition of the great arteries; RV, right ventricle; ccTGA, congenitally corrected transposition of the great arteries; CAVC, complete atri-
oventricular connection; SVC, superior vena cava; AVVR, atrioventricular valve regurgitation; PA, pulmonary artery; PLE, protein-losing enteropathy; HTX, heart
transplantation.
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Hospital cardioplegic solution (n = 87), or dilute blood,
glucose, and potassium cardioplegic solution (n = 67).
Early results. There were 12 (5.4%) early deaths.
The preoperative diagnoses and causes of death are
shown in Table I. The most common cause for early
death was ventricular dysfunction (n = 9). Two
patients could not be weaned from bypass and died in
circulatory failure. One patient died of an early post-
operative cerebral hemorrhage, and 1 patient under-
went early tricuspid replacement for severe regurgita-
tion and died later of septic complications. None of
the abovementioned patients had any structural anom-
aly of the Fontan pathway as demonstrated by post-
operative catheterization, surgical exploration, or
autopsy. However, 1 patient with heterotaxy syn-
drome and complex venous anatomy developed a
thrombus in the SVC. The thrombus was surgically
removed and the SVC enlarged with a patch, but he
died subsequently of septic complications. In 2
patients the Fontan circulation was successfully taken
down during the early postoperative period. One
patient with tricuspid atresia, left pulmonary artery
occlusion, but a well-developed right pulmonary
artery had a cardiac arrest 2 hours postoperatively. He
was supported with an extracorporeal membrane oxy-
genator, and the Fontan was later converted to a clas-
sic Glenn shunt and an aorta–left pulmonary artery
shunt. Another patient had an increase in pulmonary
vascular resistance with low cardiac output several
hours after a fenestrated Fontan procedure, requiring
conversion to a bidirectional Glenn shunt on the same
day. Multivariable analysis by logistic regression
identified single right ventricle, preoperative pul-
monary artery distortion, higher preoperative pul-
monary vascular resistance, and higher postoperative
right atrial pressure as risk factors for early failure
(Table II). When early death was considered as the
outcome parameter, hypoplastic left heart syndrome
(odds ratio = 4.8, 95% CI = 1.4-16.8, P = .04) and pul-
monary artery distortion (odds ratio = 4.3, 95% CI =
1.5-12.5, P = .03) proved the only independent risk
factors.
Mean central venous pressure on the first postopera-
tive day was 13.9 ± 2.5 mm Hg (range 7-25 mm Hg),
and mean left atrial pressure was 6.8 ± 2.2 mm Hg
(range 1-14 mm Hg). The median postoperative venti-
Table II. Predictors of failure after lateral tunnel Fontan operation
Univariable Multivariable
Variable Association P value Risk ratio* 95% CI P value
Early failure
Age at Fontan operation + .005 .18
LV-NRGA + .05 .27
Single right ventricle + .08 5.1 1.2-20.8 .04
Hypoplastic left heart syndrome + .06 .13
Right AVV stenosis or atresia + .07 .29
Left AVV stenosis or atresia + .03 .70
Pulmonary artery distortion + .01 11.7 2.8-49.3 .004
Prior atrial septectomy + .03 .21
Prior coarctation repair + .08 .39
Preop mean pulmonary artery pressure + .09 .36
Preop pulmonary vascular resistance + .08 1.8 1.1-2.8 .04
Postop right atrial pressure + .003 1.4 1.1-1.9 .02
Late failure
AVV regurgitation + .03 .55
Prior systemic–pulmonary shunt – <.001 0.07 0.02-0.45 .008
Prior pulmonary artery banding + .04 .25
Prior coarctation repair + .05 13.5 5.1-35.9 <.001
Postop right atrial pressure + .002 .62
Early postop bradyarrhythmia + .006 .54
Total failure
Prior pulmonary artery banding + .04 .25
Prior coarctation repair + .01 .1
Prior bradyarrhythmia + .02 .06
Postop right atrial pressure + .006 1.3 1.1-1.5 .005
Hypoplastic left heart syndrome + .07 .86
CI, Confidence interval; LV-NRGA, left ventricle with normally related great arteries; AVV, atrioventricular valve. 
*Risk ratio represents the odds ratio derived from logistic regression analysis for the outcome “early failure” and hazards ratio from the Cox proportional-hazards
model for the outcomes “late failure” and “total failure.” Only variables with a univariate P < .1 are shown. All variables tested are listed in the appendix.
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lation time was 11.2 hours (range 4.7 hours to 32 days),
median intensive care unit stay 2.7 days (1-93 days),
and median hospital stay 10 days (4-128 days). The
majority of the patients received inotropic drugs during
the first 2 postoperative days. Mean arterial oxygen sat-
uration at discharge was 93.7% ± 3.1% (range 89%-
98%) for patients with a closed or no fenestration and
87.1% ± 4.2% (range 79%-93%) for patients with an
open fenestration. Significant pleural effusions were
drained for longer than 14 days in 33 patients.
Table III. Predictors of SVT after the lateral tunnel Fontan operation
Univariable Multivariable
Variable Association P value Risk ratio* 95% CI P value
Early SVT
Heterotaxy syndrome + .002 7.8 2.3-23.4 .01
Prior pulmonary artery banding + .08 10.0 1.5-66.2 .02
Preop SVT + <.0001 71.5 13.7-37.2 <.0001
Late SVT
Heterotaxy syndrome + .08 .54
AVV regurgitation + .1 8.9 1.7-46.0 .03
Left AVV stenosis or atresia + .07 .45
CAVV + .009 16.9 3.1-91.4 .006
Anomalous systemic venous return + .09 .62
Prior atrial septectomy + .08 .99
Prior pulmonary artery banding + .06 .29
Prior coarctation repair + .04 .12
Preop SVT + .09 .23
Preop bradyarrhythmia + <.001 15.8 3.4-72.8 <.001
Preop pacemaker + .007 .84
Early postop SVT + <.0001 24.7 6.8-89.8 <.0001
Early postop bradyarrhythmia + .04 .64
SVT, Supraventricular tachyarrhythmia; CI, confidence interval; AVV, atrioventricular valve; CAVV, common atrioventricular valve. 
*Risk ratio represents the odds ratio derived from logistic regression analysis for the outcome “early SVT” and hazards ratio from the Cox proportional-hazards model
for the outcomes “late SVT.” Only variables with a univariate P < .1 are shown. All variables tested are listed in the appendix.
Table IV. Predictors of bradyarrhythmia after the lateral tunnel Fontan operation
Univariable Multivariable
Variable Association P value Risk ratio* 95% CI P value
Early bradyarrhythmia
Anomalous systemic venous return + .05 3.2 1.3-7.9 .01
Prior pulmonary artery banding + .03 .2
Preop bradyarrhythmia + <.0001 12.6 4.5-32.6 <.0001
Preop normofrequent junctional rhythm + .06 .26
Late bradyarrhythmia
Prior systemic/pulmonary shunt – .03 .6
Prior pulmonary artery banding + .001 3.2 1.3-8.4 .005
Prior pulmonary artery–aortic anastomosis + .05 2.9 1.2-7.5 .04
or VSD enlargement
Prior bidirectional Glenn shunt + .05 .66
Preop bradyarrhythmia + <.0001 5.1 2.0-13.1 <.0001
Preop pacemaker + .002 .48
Preop Qp/Qs + .07 .3
Baffle fenestration – .06 .25
Early postop SVT + .06 .29
Early postop bradyarrhythmia + <.0001 9.0 3.7-22.1 <.0001
Early postop pacing + .004 .24
CI, Confidence interval; VSD, ventricular septal defect; Qp/Qs, pulmonary/systemic flow ratio; SVT, supraventricular tachyarrhythmia.
*Risk ratio represents the odds ratio derived from logistic regression analysis for the outcome “early bradyarrhythmia,” and hazards ratio from the Cox proportion-
al-hazards model for the outcomes “late bradyarrhythmia.” Only variables with a univariate P < .1 are shown. All variables tested are listed in the appendix.
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Early postoperative ECG recordings, as well as
ECGs recorded before discharge, were available for all
patients. A total of 35 patients had early postoperative
arrhythmias: 11 (5%) patients had SVT, and 5 of those
were discharged on a regimen of antiarrhythmic med-
ication. Twenty-four (11%) patients had bradyarrhyth-
mia; 8 of them had a previously implanted pacemaker
and 3 more required implantation of a new pacemaker
before discharge. In a total of 173 (83%) patients, nor-
mal sinus rhythm was documented before discharge.
Independent risk factors for early SVT included het-
erotaxy syndrome and preoperative SVT (Table III).
Anomalous systemic venous return and preoperative
bradyarrhythmia were found to be predictive of early
postoperative bradyarrhythmia (Table IV).
Late results. Current follow-up information regard-
ing late mortality, morbidity, reoperations, and func-
tional status was available in 196 of the 208 (94%)
early survivors, with a mean follow-up of 10.2 ± 0.6
years (median 9.5 years, range 3.1-12.3 years).
A total of 13 late failures occurred in a total of 1931
patient-years of follow-up (0.67 per 100 patient-years).
There were 7 late deaths (Table I). In 1 patient the
cause of death could not be elucidated. Three patients
died of primary ventricular dysfunction and 1 patient of
ventricular arrhythmia. One patient died of the sequel-
ae of massive cerebral thromboembolism, and in anoth-
er patient the cause of death was found to be thrombot-
ic occlusion of the SVC and both pulmonary arteries.
The Kaplan-Meier estimates of survival for the early
survivors were 98% (97%-99%) at 5 years and 96%
(92%-99%) at 10 years (Fig 1). Including early deaths,
overall survival was estimated as 93% (89%-96%) at 5
years and 91% (86%-95%) at 10 years (Fig 1). In 2
patients the Fontan circulation was taken down during
the follow-up period for persistent pleural and pericar-
dial effusions, in both patients by conversion to a bidi-
rectional Glenn shunt. Four patients underwent heart
transplantation, the indications being progressive ven-
tricular dysfunction in 3 patients and thrombosis of the
Fontan pathway in 1 patient with heterotaxy syndrome
and complex venous anatomy (Table I). The Kaplan-
Meier estimate of freedom from failure (defined as
death or takedown) excluding early failures is 96%
(93%-99%) at 5 years and 92% (88%-96%) at 10 years
(Fig 2). Overall freedom from failure including early
failures is 90% (86%-94%) at 5 years and 87% (82%-
91%) at 10 years (Fig 2).
While univariable analysis identified several factors
that were associated with late failure, including preop-
erative atrioventricular valve regurgitation, higher early
postoperative right atrial pressure, and early postopera-
tive bradyarrhythmia, multivariable analysis by means
of the Cox proportional-hazards model revealed that
prior coarctation repair was the only independent risk
factor. Patients in whom the aorta arises from an outlet
chamber or a muscular conus may also have a subtle
degree of systemic ventricular outflow tract obstruc-
tion, potentially contributing to late myocardial dys-
function and Fontan failure. Six of the patients with
Fontan failure had relevant subaortic stenosis, and all
of them underwent a pulmonary artery–aortic anasto-
mosis before the Fontan operation. Of the other 21
Fig 1. Kaplan-Meier estimated overall survival after the lat-
eral tunnel Fontan operation. Error bars indicate the lower
95% confidence interval. Numbers of patients at risk are
shown in parentheses.
Fig 2. Kaplan-Meier estimated overall freedom from failure
after the lateral tunnel Fontan operation. “Failure” includes
death, takedown, and heart transplantation. Error bars indicate
the lower 95% confidence interval. Numbers of patients at risk
are shown in parentheses. The dashed line represents the
Kaplan-Meier estimate of freedom from Fontan failure after
Fontan operations performed between 1973 and 1984 in our
institution, before the introduction of the lateral tunnel modifi-
cation (data previously published by Gentles and associates10).
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patients with Fontan failure, 11 had transposition or
malposition of the great arteries and hence the potential
for development of some degree of systemic ventricu-
lar outflow tract obstruction. This may indeed indicate
the possibility of a subtle systemic ventricular outflow
tract obstruction as a factor contributing to Fontan fail-
ure, but when a potentially predisposing anatomy was
examined as a variable in the entire cohort, we did not
find a significant impact on outcome. When the total
number of Fontan failures was evaluated as the out-
come parameter, higher postoperative right atrial pres-
sure was found to be predictive of poorer outcome
(Table II). With respect to late death only, prior pace-
maker insertion was the sole multivariable predictor
(hazard ratio = 16.1, 95% CI = 6.0-42.8, P < .001).
Both prior coarctation repair (hazard ratio = 8.9, 95%
CI = 2.7-29.6, P = .003) and single right ventricle (haz-
ard ratio = 7.7, 95% CI = 2.2-27.2, P = .009) were inde-
pendently predictive of overall higher risk for death.
The baffle fenestration was closed during the follow-
up period in 77 patients by means of a transcatheter
device. The fenestration is known to have closed spon-
taneously in 25 patients. Two patients had a mild
obstruction of the Fontan connection located at the
anastomosis between the proximal SVC and the pul-
monary artery; these obstructions were successfully
relieved by balloon dilation and stent placement. In 11
patients a leak in the intra-atrial baffle was identified
and closed by transcatheter (n = 5) or surgical (n = 1)
means. Other late reoperations or reinterventions
included embolization of systemic–pulmonary arterial
collaterals (n = 2), pulmonary artery dilation (n = 5) or
surgical plasty (n = 1), relief of subaortic outflow tract
obstruction (n = 3), creation of a pericardial window (n
= 4), and creation of a baffle fenestration (n = 1).
Follow-up cardiac catheterization data were available
for 101 patients and echocardiograms for 130 patients.
Mean aortic oxygen saturation at follow-up was 91% ±
4.6% (77%-97%), and mean central venous pressure
was 11.4 ± 3.2 mm Hg (7-22 mm Hg).
ECGs recorded during late follow-up were available
for review in 114 (59%) patients. In 67 (35%) patients
the information about current cardiac rhythm was
obtained from filed correspondence. Holter recordings
were available for 38 (20%) patients. The median inter-
val between the Fontan operation and most recent ECG
recording was 8.7 years (range 3-12.3 years). For 12
patients no recent ECG recording or report was avail-
able. SVT was reported in 12 (5.5%) patients during
the follow-up period, 1 of whom was known to have a
history of preoperative SVT. The overall freedom from
symptomatic or documented postoperative SVT inci-
dents was 94% (91%-97%) at 5 years and 90% (85%-
95%) at 10 years. When patients with preoperative
SVT are excluded, the freedom from new postoperative
SVT is 96% (93%-99%) at 5 years and 91% (86%-
96%) at 10 years (Fig 3). Freedom from late-onset SVT
is 98% (97%-99%) at 5 years and 94% (92%-97%) at
10 years. The proportions of patients having preopera-
tive SVT (7/220, 3.2%) and those having SVT during
recent follow-up (7/192, 3.6%) were not different 
(P = .9, Fisher exact test). Numerous variables were
associated with late SVT in the univariable analyses,
including heterotaxy syndrome, anomalous systemic
venous return, prior atrial septectomy, preoperative
SVT, and early postoperative bradyarrhythmia.
However, the Cox model established 4 important pre-
dictors: atrioventricular valve regurgitation, common
atrioventricular valve, preoperative bradyarrhythmia,
and early postoperative SVT (Table III). When the
onset of new postoperative SVT was considered as the
outcome parameter, the presence of a common atri-
oventricular valve was the only multivariable risk fac-
tor (hazard ratio = 4.7, 95% CI = 1.5-15.6, P = .03).
A total of 32 patients (15.3%) had an incident of
postoperative bradyarrhythmia documented during the
follow-up period; 9 of those also had preoperative
bradyarrhythmia and 11 early postoperative brady-
arrhythmia. In addition to manifest bradyarrhythmias,
12 (6%) patients had atrial junctional rhythm with nor-
Fig 3. Kaplan-Meier estimated overall freedom from new
SVT after the lateral tunnel Fontan operation. New SVT is
defined as postoperative occurrence of SVT excluding
patients who had preoperative SVT. Error bars indicate the
lower 95% confidence interval. Numbers of patients at risk
are shown in parentheses. The dashed line represents the
Kaplan-Meier estimate of freedom from atrial flutter after a
Fontan operation with direct atriopulmonary anastomosis in
patients operated on between 1973 and 1989 in our institution
(data previously published by Fishberger and associates12).
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mal heart rate at most recent follow-up; 11 of them also
had preoperative junctional rhythm. Estimated freedom
from new postoperative bradyarrhythmia was 88%
(83%-92%) at 5 years and 79% (72%-86%) at 10 years
(Fig 4). Freedom from late-onset bradyarrhythmia was
94% (91%-97%) at 5 years and 89% (83%-94%) at 10
years. When patients with permanent preoperative
bradyarrhythmia are included, the overall freedom
from bradyarrhythmia was estimated to be 83% (83%-
92%) at 5 years and 73% (67%-79%) at 10 years.
Twenty-seven (14%) of the 192 patients had brady-
arrhythmia at the time of most recent follow-up, as
compared with 27 (12%) of 220 patients who had pre-
operative bradyarrhythmia (P = .42). Again, there were
numerous univariable factors associated with late
bradyarrhythmia, such as a prior bidirectional Glenn
shunt and early postoperative SVT. Besides a prior pul-
monary artery–aortic anastomosis or VSD enlargement
and prior pulmonary artery banding, the most impor-
tant independent multivariable risk factors for late
bradyarrhythmia were preoperative and early postoper-
ative bradyarrhythmia (Table IV). When the onset of
new postoperative bradyarrhythmia was considered as
the outcome parameter, no variables were found to be
independently predictive in the Cox regression model.
Enlargement of the proximal cavopulmonary anasto-
mosis by incising the cavoatrial junction and the roof of
the right-sided atrium did not prove a risk factor for
early or late bradyarrhythmia.
A pacemaker was implanted during the follow-up
period in 7 patients, with epicardial leads placed on the
ventricular and atrial surfaces after median sternotomy.
Four of those had isolated bradyarrhythmia and 3
patients had sick sinus syndrome with recurrent atrial
flutter. The indications for pacemaker insertion were
documented bradyarrhythmia with heart rates less than
50 beats/min in 5 patients and symptomatic brady-
arrhythmic episodes with heart rates more than 50
beats/min in 2 patients.
Functional state. A New York Heart Association
functional class was assigned by the primary physician
or cardiologist in 183 patients. Seventy-five (41%) of
the patients were in functional class I, 97 patients
(53%) were in class II, 11 patients (6%) were in class
III, and no patient was in class IV. A medication histo-
ry was available in 169 patients. One hundred twelve
patients were receiving no cardiac medications at the
time of follow-up, 39 patients were receiving one car-
diac medication, and 18 were receiving two or more
cardiac medications. Antiarrhythmic medication other
than digoxin was required by 13 patients. There was no
uniform policy regarding the indication for long-term
anticoagulation. Twenty-seven patients with reduced
ventricular function and/or chronic atrial flutter or fib-
rillation received warfarin sodium (Coumadin). Platelet
inhibition with aspirin 80 mg/day by mouth was per-
formed in 118 patients.
Neurologic symptoms were present in a total of 7
patients. In 2 patients a hemiplegia developed 3 and 14
months, respectively, after the Fontan operation. Both
had open fenestrations, but no source of emboli was
identified. Two patients have seizures, 1 of unknown
cause and 1 after a septic brain abscess. Three other
patients have mild choreoathetosis symptoms, all after
uncomplicated hospital courses. Apart from 2 patients
with thrombotic occlusion of the SVC, 1 patient with
late baffle thrombosis, 1 patient with massive cerebral
thromboembolism, and 2 patients with stroke and
hemiplegia, there were no proven or suspected throm-
boembolic complications in this series. Protein-losing
enteropathy with persistent or recurrent edema,
hypoproteinemia, and enteric α1-antitrypsin loss devel-
oped in 1 patient with transposition of the great arteries
and Ebstein anomaly. He had moderate tricuspid valve
regurgitation and underwent a modified Stansel anasto-
mosis for subaortic obstruction 22 months after the
Fontan operation. However, his protein-losing
enteropathy did not improve, and he eventually under-
went cardiac transplantation, resulting in complete
remission. Two further patients had evidence of pro-
tein-losing enteropathy in the form of recurrent ascites
and hypoproteinemia, for which they were successful-
Fig 4. Kaplan-Meier estimated freedom from new brady-
arrhythmia after the lateral tunnel Fontan operation. New
bradyarrhythmia is defined as postoperative occurrence of
bradyarrhythmia excluding patients who had preoperative
bradyarrhythmia. Error bars indicate the lower 95% confi-
dence interval. Numbers of patients at risk are shown in
parentheses.
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ly treated with diuretics and angiotensin-converting
enzyme inhibitors.
Discussion
The present study demonstrates that the lateral tunnel
Fontan procedure results in excellent long-term sur-
vival and freedom from failure in patients with a wide
range of underlying cardiac malformations. The inci-
dence of new SVT is low, but a number of patients will
have some form of bradyarrhythmia during follow-up.
However, a large proportion of lateral tunnel Fontan
patients with bradyarrhythmia already had sinus node
dysfunction before the operation, mainly associated
with structural anomalies or previous surgical proce-
dures.
Although the surgical results of the Fontan operation
for complex cardiac malformations are steadily improv-
ing, it has become evident that considerable late mor-
bidity develops with increasing follow-up time.10,16-18
This has been demonstrated clearly for the atriopul-
monary types of Fontan circulation but remains to be
defined for more recent modifications, such as the later-
al tunnel and the total extracardiac Fontan operation.
There is experimental evidence that the intra-atrial
suture line alone is able to facilitate inducible sustained
atrial flutter19 and that the fluid dynamics in the lateral
tunnel are characterized by slightly greater fluid-power
loss compared with the extracardiac cavopulmonary
connection.20 We therefore chose to determine the long-
term results in a group of patients invariably treated with
a lateral tunnel Fontan operation, which, in our institu-
tion, is used most often.
Although late mortality and morbidity in our series
are low, a significant number of patients have late post-
operative bradyarrhythmia. Because of the mostly per-
manent nature of bradyarrhythmias, preoperative and
early postoperative bradyarrhythmia proved to be the
most potent predictors of late bradyarrhythmia, fol-
lowed by structural anomalies of the systemic venous
return, a feature of many malformations that are asso-
ciated with abnormalities of the conduction system.
Regarding the 2 procedure-related variables with sig-
nificant impact on the prevalence of late bradyarrhyth-
mia, prior pulmonary artery banding and prior pul-
monary artery–aortic anastomosis, there seems to be no
obvious cause-effect relationship. A staged approach to
completion of the Fontan circulation was previously
found to increase the risk of postoperative brady-
arrhythmia, but in the current analysis a prior bidirec-
tional Glenn shunt proved to be a risk factor in the uni-
variable analysis only.21 However, it is notable that 7 of
the 10 patients with preoperative junctional rhythm at a
physiologic rate had had a previous Glenn shunt. As
pointed out before, the proximal cavopulmonary anas-
tomosis was enlarged by incising the roof of the right-
sided atrium in patients with a relatively small SVC
orifice. An incision across the superior cavoatrial junc-
tion may damage the sinus node artery, since the vessel
is difficult to identify during cardioplegic arrest.
Interestingly, however, we did not observe a correlation
between an incision across the cavoatrial junction and
the incidence of postoperative bradyarrhythmia.
Exposure of the entire atrium to elevated pressure in
the Fontan circuit can lead to progressive distention
with atrial enlargement and development of supraven-
tricular arrhythmias. Whether incorporation of only a
small area of the lateral atrial wall in the Fontan circu-
lation, as in the lateral tunnel modification, has similar
deleterious effects on atrial conduction remains
unclear. The presence of long intra-atrial suture lines as
necessary for implantation of the lateral tunnel is
thought to facilitate the development of slow reentry
circuits and hence atrial flutter.19 This has indeed been
demonstrated by intra-atrial mapping and programmed
stimulation in a number of patients after the lateral tun-
nel Fontan operation. The proportion of patients in
whom reentry circuits actually lead to arrhythmias is
not completely clear. However, our data indicate that
very few patients have symptomatic tachycardias with-
in the first 10 years after the operation. When
Fishberger and associates12 presented the Children’s
Hospital Boston experience with arrhythmias after the
modified Fontan operation, they noted a trend to a
lower incidence of postoperative tachyarrhythmias
after a lateral tunnel Fontan operation as compared
with other modifications. Because of the limited num-
ber of patients and short follow-up, the difference did
not reach statistical significance. However, in the pre-
sent study we could clearly demonstrate that the low
incidence of SVT persists for at least up to 10 years
after the lateral tunnel Fontan procedure. Reviewing
the extensive literature on the development of
supraventricular arrhythmia after the Fontan operation,
we noticed that the incidence of SVT after lateral tun-
nel Fontan modifications in other studies is also
low.3,6,22 This suggests that, although the suture line
may be highly arrhythmogenic in animal models, other
factors may play a more important role in the clinical
evolution of this arrhythmia. Only one report, a com-
parative study from the Mayo Clinic, suggests that
patients after a lateral tunnel Fontan are at the same risk
for early and late SVT as patients with other types of
Fontan connections.23 Moreover, the risk for late SVT
after a total cavopulmonary connection was higher than
after an atriopulmonary connection with an intra-atrial
lateral tunnel.
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The proponents of a total extracardiac Fontan proce-
dure, using a tubular conduit or an extracardiac tunnel
incorporating atrial wall, have suggested that this mod-
ification may minimize the incidence of atrial arrhyth-
mia.24-26 Although several theoretical arguments sup-
port this hypothesis, the detailed study by Shirai and
colleagues27 demonstrated that 11 of 15 patients after
an extracardiac Fontan operation had some form of
bradyarrhythmia at follow-up. In addition, 3 patients
had a thrombus located in the external Fontan conduit.
In our series, heterotaxy syndrome proved the only
patient-related risk factor for early SVT in the multi-
variable model and a univariable risk factor for late
SVT. Patients with heterotaxy syndrome have consis-
tently been shown to be at greater risk of both early and
late mortality and morbidity.28,29 Numerous abnormal-
ities of the conduction system exist that may provoke
tachyarrhythmia and bradyarrhythmia irrespective of
the type of Fontan repair. In patients with left iso-
merism, interrupted IVC, and azygos continuation, we
prefer to use a lateral tunnel to direct the hepatic
venous flow to the cavopulmonary anastomosis when-
ever the intra-atrial anatomy allows. This is important
to avoid the development of pulmonary arteriovenous
communications due to a lack of “hepatic factor” in the
pulmonary circulation. Since blood flow through the
conduit from hepatic veins only is lower than from a
regular IVC, a tubular intracardiac or extracardiac con-
duit may be at increased risk of thrombosis.
The risk factors for failure of the Fontan circulation
and the proposed selection criteria for a Fontan-type
repair have been described frequently. However, many
of the exclusion criteria have been relaxed with
improving perioperative management and surgical
modifications. The present cohort was operated on
within a relatively narrow time window with one prin-
cipal surgical technique with only slight modifications.
Hence, it is not surprising that early outcome was only
determined by “classic” patient-related risk factors
such as a single right ventricle, pulmonary artery dis-
tortion, pulmonary vascular resistance, and postopera-
tive right atrial pressure. Although our principal treat-
ment strategy has since been unchanged, it is likely that
further improvements in perioperative management
during the past decade, such as better defined indica-
tions for insertion and closure of the baffle fenestration
or the use of inhaled nitric oxide during the early post-
operative period, have further limited the number of
early risk factors.30,31 The long-term outcome is more
likely to reflect advances in surgical technique, and the
only independent predictor of late failure was prior
coarctation repair. Whether this surprising finding is
incidental or reflects late effects of early systemic ven-
tricular pressure overload remains to be determined.
Another explanation would be residual or recurrent
coarctation in these patients. However, we did not find
any evidence for that in patients with a failing Fontan
circulation.
Limitations of the study
The validity of our study is clearly limited by its ret-
rospective nature. Although long-term follow-up infor-
mation was available for a large number of patients, the
incidence of bradyarrhythmia and transient SVT is
most likely underestimated because of the transient and
intermittent nature of some arrhythmias and the limited
availability of serial ECG and Holter studies. On the
other hand, we did not distinguish between sympto-
matic and asymptomatic arrhythmias, and only a frac-
tion of the recorded arrhythmic events required treat-
ment. Similarly, the incidence of thromboembolic
complications is probably underestimated, because
only clinically relevant events came to our attention.
For instance, Balling and associates32 have recently
reported right atrial thrombus formation in 33% of
asymptomatic patients having the Fontan operation,
although all of the thrombus-positive patients had
either atriopulmonary or atrioventricular Fontan modi-
fications. The same must be said regarding the inci-
dence of protein-losing enteropathy, which can be bet-
ter assessed by prospective analysis of enteric
α1-antitrypsin loss. Since the absolute number of late
events is small, further caution is recommended when
interpreting the results of the risk factor analyses. With
respect to the early results, it should also be remem-
bered that the cohort represents our early experience
with the lateral tunnel Fontan operation, and, as point-
ed out before, further advances in early postoperative
treatment have probably led to a further decrease in
early mortality and morbidity. Our retrospective analy-
sis can by no means replace prospective studies of
long-term Fontan complications such as arrhythmias,
thromboembolism, or organ dysfunction. Instead, it
may serve as a basis for the design of future studies
clarifying the long-term morbidity of patients with
modern Fontan modifications.
Conclusions
By extending the limits for the Fontan procedure, we
treat many patients with severe cardiac malformations
that carry an intrinsic higher risk of late morbidity and
mortality irrespective of the nature of palliative proce-
dures.18 On the basis of favorable long-term outcome,
the lateral tunnel Fontan operation remains our pre-
The Journal of Thoracic and
Cardiovascular Surgery
Volume 121, Number 1
Stamm et al 39
ferred method to establish a Fontan circulation for a
wide range of underlying cardiac malformations.
However, further prospective studies clarifying the
long-term morbidity of modern Fontan modifications
are clearly needed.
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Appendix
Variables tested for influence on early and late outcome
parameters
Patient-related
Demographics
Age at Fontan operation
Sex
Time since Fontan operation
Diagnosis
Morphologically left ventricle with normally related great arteries
Morphologically left ventricle with transposed great arteries
Morphologically right ventricle and ventricle with unknown 
morphology
Hypoplastic left heart syndrome
Heterotaxy syndrome
Anomalous pulmonary venous drainage
Atrioventricular valve regurgitation
Pulmonary artery distortion
Atrioventricular valve morphology
Left atrioventricular valve stenosis or atresia
Right atrioventricular valve stenosis or atresia
Double-inlet ventricle
Common atrioventricular canal
Pulmonary artery distortion
Prior procedures
Systemic–pulmonary artery shunt
Pulmonary artery band
Coarctation repair (including hypoplastic left heart syndrome
with distinct coarctation)
Atrial septectomy
Pulmonary artery–aortic anastomosis or VSD enlargement
Atrioventricular valve repair
Bidirectional Glenn shunt or hemi-Fontan operation
Pulmonary artery reconstruction
Pacemaker implantation
Preoperative hemodynamics
Arterial oxygen saturation
Hemoglobin
Left atrial pressure
Right atrial pressure
Mean pulmonary artery pressure
Pulmonary vascular resistance
Pulmonary/systemic flow ratio
Pulmonary plus systemic flow
Preoperative supraventricular tachyarrhythmia
Preoperative bradyarrhythmia
Preoperative atrial junctional rhythm
Procedure-related variables
Cardiopulmonary bypass time
Aortic crossclamp time
Surgeon
Concomitant procedures
Baffle fenestration
Incision of cavoatrial junction/atrial roof
Atrial septectomy
Pulmonary arterioplasty
Atrioventricular valve repair
Relief of subaortic obstruction
Postoperative variables
Right atrial pressure on postoperative day 1
Duration of intensive care unit stay
Early postoperative SVT
Early postoperative bradyarrhythmia
Early postoperative atrial junctional rhythm
Early postoperative ventricular pacing
Early postoperative atrial pacing
Early postoperative atrioventricular pacing
Fenestration closure
Pleural effusions > 14 days
Need for catheter or surgical intervention other than fenestration
closure
Duration of hospital stay
Discussion
Dr Gordon K. Danielson (Rochester, Minn). Dr Stamm has
reminded me that I was privileged to discuss Marc de Leval’s
now classic presentation on the hydrodynamics of total pul-
monary connection at the 1988 meeting of this Association.
Some of the issues raised at that time have been answered by
Dr Stamm’s detailed review and by reports of others, specifi-
cally the reduced incidence of right atrial thrombus in the
more streamlined atrial channel and a lower incidence of atri-
al tachyarrhythmias due to exclusion of most of the right atri-
um from increased systemic venous pressure. Dr Stamm’s
review confirms the views that there are also other factors
causally associated with atrial tachyarrhythmias, including
some on the systemic side of the circulation, particularly atri-
oventricular valve abnormalities and incompetence. 
It is difficult to prove that the presence and location of atri-
al suture lines are important risk factors for atrial tachy-
arrhythmias in Fontan patients, although increasing evidence
suggests that they may be. For example, there are several
ways to construct a lateral tunnel. In our experience, patients
with a baffle sewn to the crista terminalis had nearly twice the
incidence of late atrial tachyarrhythmias as did those with a
baffle sewn anterior to and well removed from the crista ter-
minalis. The authors point out that Dr James Cox and his col-
leagues have shown experimentally that injury to the crista
terminalis produces a substrate for atrial flutter. 
My first question for Dr Stamm is as follows: Was the loca-
tion of the atrial baffle suture line in reference to the crista
mentioned in the operative notes? If so, was it possible to
compare cases with and without suture lines in the crista? 
With regard to bradyarrhythmias, there was a 10-year prob-
ability of the development of a new bradyarrhythmia of 21%
in your series. In 62 patients an incision was made down the
SVC and across the roof of the right atrium, probably injur-
ing the sinus node blood supply. This variable was not listed
in your Table IV, but in the discussion you mentioned that a
correlation was not noted between this incision and the inci-
dence of postoperative bradyarrhythmias. Can you explain
this counterintuitive finding? 
Incidentally, one advantage of the lateral tunnel compared
with an extracardiac or intracardiac tube is the ability to place
a transvenous atrial pacemaker for this progressively enlarg-
ing subset of patients with atrial arrhythmias. Some issues
regarding the lateral tunnel total cavopulmonary connection
that are still undecided, at least in my understanding, include
the long-term effect of offsetting the caval anastomoses in
regard to pulmonary arteriovenous fistulas in the lung that
receives little or no hepatic flow, as well as the importance
immediately preceded this meeting, in which he explained in
detail the technique that is currently used at Children’s Hospital.
My understanding is that we prefer not to suture the intra-atrial
baffle to the crista terminalis itself, being aware of the possible
increased incidence of arrhythmia that might result.
With respect to your second question, we did indeed study
whether the incision in the roof of the right atrium had an
impact on the incidence of sinus node dysfunction, which it
did not have. We will add that information to the manuscript. 
The Journal of Thoracic and
Cardiovascular Surgery
Volume 121, Number 1
Stamm et al 41
and tradeoffs regarding the best way to place and fashion the
cavopulmonary anastomoses. This excellent analysis of the
early and late results of the intracardiac lateral tunnel Fontan
procedure will serve well as a basis for comparisons with the
other surgical modifications. 
Dr Stamm. Thank you very much for your comments, Dr
Danielson. 
With respect to your first question, I would like to refer to Dr
Mayer’s excellent presentation in the postgraduate course that
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